Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 22
Filtrar
1.
Phytomedicine ; 53: 107-123, 2019 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-30668390

RESUMO

BACKGROUND: Lung cancer is one of the most lethal cancers and lacks effective treatment strategy. Therapeutic efficacy can be improved through active targeting approach utilizing surface engineered nanoparticles (NPs) for cancer therapy. PURPOSE: The present study envisioned development of Folic acid (FA) functionalized NPs for co-administration of gefitinib (Gnb) and capsaicin (Cap) respectively to enhance the therapeutic outcome by disabling the barriers related to tumors extracellular matrix. RESEARCH METHODS AND PROCEDURE: The FA conjugated Gnb/Cap polymeric (PLGA-PEG) NPs were prepared using oil in water emulsion technique and methodically developed using Quality by Design (QbD) concept employing central composite design. The developed formulations were subjected to various in vitro (A549 cell lines) and in vivo evaluations in urethane-induced lung cancer. RESULTS: The modified NPs displayed particle sizes of 217.0 ±â€¯3.2 nm and 213.0 ±â€¯5.2 nm and drug release of 85.65 ±â€¯3.21% and 81.43 ±â€¯4.32% for Gnb and Cap respectively. Higher cellular uptake and lower cell viability in A549 cell line was displayed by functionalized NPs compared to free drug. Co administration of Gnb and Cap NPs displayed significant targeting potential, reduction in tumor volume while restoring the biochemical parameters viz., SOD, catalase, TBARS and protein carbonyl, towards normal levels when compared with toxic group. Significant down regulation was observed for anti-apoptotic proteins (MMP-9) and up regulation of pro-apoptotic proteins (caspase-3, caspase-9 and MMP-9) with co-therapy of Gnb and Cap NPs, when compared with individual therapy through Gnb/Cap. CONCLUSION: Potentiation of the action of Gnb when co administered with Cap NPs can be a promising breakthrough for developing safe, effective and targeted delivery for lung carcinoma therapy.


Assuntos
Protocolos de Quimioterapia Combinada Antineoplásica/farmacologia , Sistemas de Liberação de Medicamentos/métodos , Ácido Fólico/química , Neoplasias Pulmonares/tratamento farmacológico , Nanopartículas/administração & dosagem , Células A549 , Animais , Protocolos de Quimioterapia Combinada Antineoplásica/administração & dosagem , Protocolos de Quimioterapia Combinada Antineoplásica/farmacocinética , Apoptose/efeitos dos fármacos , Capsaicina/administração & dosagem , Sobrevivência Celular/efeitos dos fármacos , Regulação para Baixo/efeitos dos fármacos , Liberação Controlada de Fármacos , Feminino , Ácido Fólico/administração & dosagem , Gefitinibe/administração & dosagem , Humanos , Neoplasias Pulmonares/induzido quimicamente , Neoplasias Pulmonares/patologia , Masculino , Metaloproteinase 9 da Matriz/metabolismo , Nanopartículas/química , Tamanho da Partícula , Poliésteres/química , Polietilenoglicóis/química , Ratos Wistar , Uretana/toxicidade
2.
Artigo em Inglês | MEDLINE | ID: mdl-29452256

RESUMO

Polyunsaturated fatty acids (PUFA's) are majorly classified as ω-3 and ω-6 fatty acids. The eicosapentaenoic acid (EPA, ω-3:20-5), docosahexaenoic acid (DHA, ω-3:22-6) and alpha-linolenic acid (ALA, ω-3:18-3) are known ω-3 fatty acids, extracted from animal (e.g fish oil) and plant sources (e.g flaxseed oil). Furthermore, linoleic acid (LA, ω-6:18-2) is recognized as ω-6 fatty acid and the most prominent biological fatty acid with a pro-inflammatory response. Flaxseed oil has variety of biological roles, due to the significant amount of ω-3/ω-6 fatty acids. Numerous studies have reported that ALA (ω-3:18-3) and LA (ω-6:18-2) has diverse pharmacological activities. The ALA (ω-3:18-3) and LA (ω-6:18-2) are recognised to be the pharmacological antagonist. For example, ALA (ω-3:18-3) is recognised as anti-inflammatory, whereas LA (ω-6:18-2) is considered to be pro-inflammatory. PUFA's get oxidized in three ways; firstly, free radical-mediated pathway, secondly non-free radical non-enzymatic metabolism, and lastly enzymatic degradation. The present report is an attempt to summarize various modes of PUFA's metabolism and elaborate biological effects of the associated metabolites concerning flaxseed oil.


Assuntos
Óleo de Semente do Linho/farmacologia , Peroxidação de Lipídeos/efeitos dos fármacos , Estresse Oxidativo/efeitos dos fármacos , Animais , Ácidos Graxos Ômega-3/farmacologia , Ácidos Graxos Ômega-6/farmacologia , Humanos
3.
Int J Biochem Cell Biol ; 96: 51-62, 2018 03.
Artigo em Inglês | MEDLINE | ID: mdl-29355756

RESUMO

The aim of the present study is to evaluate the effect of gamma linolenic acid (GLA) on mitochondrial mediated death apoptosis, hypoxic microenvironment and cholinergic anti-inflammatory pathway against 7, 12-dimethylbenz (a) anthracene (DMBA) induced mammary gland carcinoma. The effects of GLA were evaluated morphologically and biochemically against DMBA induced mammary gland carcinoma. The metabolic study was done for evaluation of biomarkers using 1H NMR. The present study was also verified through immunoblotting and qRT-PCR studies for the evaluation of various pathways. GLA treatment has a delineate implementation upon morphology of the tissues when evaluated through carmine staining, hematoxyline and eosin staining and scanning electron microscopy. GLA also demarked a commendatory proclamation of the fifteen key serum metabolites analogous with amino acid metabolism and fatty acid metabolism when recognized through1H NMR studies. The immunoblotting and qRT-PCR studies accomplished that GLA mediated mitochondrial death apoptosis, curtail hypoxic microenvironment along with hindrance of de novo fatty acid synthesis and also mediate the cholinergic anti-inflammatory pathway to proclaim its anticancer effects.


Assuntos
Antracenos/toxicidade , Apoptose/efeitos dos fármacos , Neoplasias Mamárias Experimentais/metabolismo , Mitocôndrias/metabolismo , Proteínas de Neoplasias/metabolismo , Piperidinas/toxicidade , Pró-Colágeno-Prolina Dioxigenase/metabolismo , Hipóxia Tumoral/efeitos dos fármacos , Ácido gama-Linolênico/farmacologia , Animais , Feminino , Prolina Dioxigenases do Fator Induzível por Hipóxia , Neoplasias Mamárias Experimentais/induzido quimicamente , Neoplasias Mamárias Experimentais/patologia , Mitocôndrias/patologia , Ratos , Ratos Wistar
4.
J. physiol. biochem ; 73(2): 187-198, mayo 2017. graf, tab, ilus
Artigo em Inglês | IBECS | ID: ibc-168475

RESUMO

The present study was undertaken to elucidate the effect of alpha-linolenic acid (ALA, 18:3, ω-3) and gamma-linolenic acid (GLA, 18:3, ω-6) on experimental autism features induced by early prenatal exposure to valproic acid (VPA) in albino wistar pups. The pups were scrutinized on the accounts of behavioral, biochemical, and inflammatory markers, and the results suggested that the GLA can impart significant protection in comparison to ALA against VPA-induced autism features. When scrutinized histopathologically, the cerebellum of the GLA-treated animals was evident for more marked protection toward neuronal degeneration and neuronal loss in comparison to ALA. Concomitant administration of ALA and GLA with VPA demonstrated a marked cutdown in the Pgp 9.5 expression with GLA having more pronounced effect. Henceforth, it can be concluded that ALA and GLA can impart favorable protection against the VPA-induced autism-like features with GLA having pronounced effect (AU)


No disponible


Assuntos
Animais , Ratos , Transtorno Autístico/prevenção & controle , Anti-Inflamatórios não Esteroides/uso terapêutico , Ácido alfa-Linolênico/uso terapêutico , Modelos Animais de Doenças , Suplementos Nutricionais/efeitos adversos , Ácido gama-Linolênico/uso terapêutico , Fármacos Neuroprotetores/uso terapêutico , Anticonvulsivantes/toxicidade , Antimaníacos/toxicidade , Comportamento Animal , Ácido Valproico/toxicidade , Ubiquitina Tiolesterase/metabolismo , Estresse Oxidativo , Biomarcadores , Ratos Wistar , Proteínas do Tecido Nervoso/metabolismo
5.
Inflammopharmacology ; 25(1): 159-175, 2017 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-28155120

RESUMO

A new compound derivative of glycoside 19-α-hydroxy-ursolic acid glucoside (19-α-hydroxyurs-12(13)-ene-28-oic acid-3-O-ß-D-glucopyranoside (HEG) was isolated from whole plant of Wedelia calendulacea (Compositae). The structure was elucidated and established by standard spectroscopy approaches. Diethylnitrosamine (DEN) (200 mg/kg) and ferric nitrilotriacetate (Fe-NTA) (9 mg/kg) were used for induction of renal cell carcinoma (RCC) in the rats. The rats were further divided into different groups and were treated with HEG doses for 22 weeks. Anti-cancer effect in RCC by HEG was dose dependent to restrict the macroscopical changes as compared to DEN + Fe-NTA-control animals. Significant alteration in biochemical parameters and dose-dependent alleviation in Phase I and Phase II antioxidant enzymes were responsible for its chemo-protective nature. HEG in dose-dependent manner was significant to alter the elevated levels of pro-inflammatory cytokines and inflammatory mediators during RCC. The histopathological changes were observed in the HEG pre-treated group, which was proof for its safety concern as far as its toxicity is concerned. The isolated compound HEG can impart momentous chemo-protection against experimental RCC by suppressing the cyclooxygenase (COX-2) and prostaglandin E2 (PGE2) expression via nuclear factor-kappa B (NF-κB) pathway.


Assuntos
Ciclo-Oxigenase 2/metabolismo , Dinoprostona/metabolismo , Glicosídeos/uso terapêutico , Neoplasias Renais/metabolismo , NF-kappa B/metabolismo , Wedelia , Animais , Dietilnitrosamina/toxicidade , Dinoprostona/antagonistas & inibidores , Relação Dose-Resposta a Droga , Regulação para Baixo/efeitos dos fármacos , Regulação para Baixo/fisiologia , Glicosídeos/isolamento & purificação , Glicosídeos/farmacologia , Neoplasias Renais/induzido quimicamente , Neoplasias Renais/prevenção & controle , Masculino , NF-kappa B/antagonistas & inibidores , Extratos Vegetais/isolamento & purificação , Extratos Vegetais/farmacologia , Extratos Vegetais/uso terapêutico , Ratos , Ratos Wistar , Transdução de Sinais/efeitos dos fármacos , Transdução de Sinais/fisiologia
6.
J Physiol Biochem ; 73(2): 187-198, 2017 May.
Artigo em Inglês | MEDLINE | ID: mdl-27878518

RESUMO

The present study was undertaken to elucidate the effect of alpha-linolenic acid (ALA, 18:3, ω-3) and gamma-linolenic acid (GLA, 18:3, ω-6) on experimental autism features induced by early prenatal exposure to valproic acid (VPA) in albino wistar pups. The pups were scrutinized on the accounts of behavioral, biochemical, and inflammatory markers, and the results suggested that the GLA can impart significant protection in comparison to ALA against VPA-induced autism features. When scrutinized histopathologically, the cerebellum of the GLA-treated animals was evident for more marked protection toward neuronal degeneration and neuronal loss in comparison to ALA. Concomitant administration of ALA and GLA with VPA demonstrated a marked cutdown in the Pgp 9.5 expression with GLA having more pronounced effect. Henceforth, it can be concluded that ALA and GLA can impart favorable protection against the VPA-induced autism-like features with GLA having pronounced effect.


Assuntos
Anti-Inflamatórios não Esteroides/uso terapêutico , Transtorno Autístico/prevenção & controle , Suplementos Nutricionais , Modelos Animais de Doenças , Fármacos Neuroprotetores/uso terapêutico , Ácido alfa-Linolênico/uso terapêutico , Ácido gama-Linolênico/uso terapêutico , Animais , Animais Recém-Nascidos , Anti-Inflamatórios não Esteroides/efeitos adversos , Anticonvulsivantes/toxicidade , Antimaníacos/toxicidade , Transtorno Autístico/induzido quimicamente , Transtorno Autístico/imunologia , Transtorno Autístico/patologia , Comportamento Animal/efeitos dos fármacos , Biomarcadores/sangue , Biomarcadores/metabolismo , Encéfalo/efeitos dos fármacos , Encéfalo/imunologia , Encéfalo/metabolismo , Encéfalo/patologia , Suplementos Nutricionais/efeitos adversos , Mediadores da Inflamação/sangue , Mediadores da Inflamação/metabolismo , Proteínas do Tecido Nervoso/metabolismo , Neurônios/efeitos dos fármacos , Neurônios/imunologia , Neurônios/metabolismo , Neurônios/patologia , Fármacos Neuroprotetores/efeitos adversos , Estresse Oxidativo/efeitos dos fármacos , Ratos Wistar , Ubiquitina Tiolesterase/metabolismo , Ácido Valproico/toxicidade , Ácido alfa-Linolênico/efeitos adversos , Ácido alfa-Linolênico/sangue , Ácido alfa-Linolênico/metabolismo , Ácido gama-Linolênico/efeitos adversos , Ácido gama-Linolênico/sangue , Ácido gama-Linolênico/metabolismo
7.
BMC Complement Altern Med ; 16(1): 510, 2016 Dec 07.
Artigo em Inglês | MEDLINE | ID: mdl-27927194

RESUMO

BACKGROUND: Natural products use for arthritis treatment is gaining importance in the medical worldt. Various studies reports medical importance of Melastoma malabathricum Linn. (MM) (Melastomataceae), also known as "putki," has a broad range of health benefits, for its free radical scavenging constituents. The current investigation scrutinizes the antioxidant and anti-inflammatory effect of MM against adjuvant-induced arthritis in experimental rats. METHODS: High-performance thin layer chromatography (HPTLC) was used for estimation of phytochemical-constituents present in the MM extract. Protective effect of MM extract in Wistar rats was estimated using CFA-induced model. The rats were divided into different groups with six rats in each group. All animals received oral administration of MM and indomethacin for 28 days. The body weight and arthritic score were scrutinized at regular intervals. At the end of experimental protocol, the rats were sacrificed, and blood samples were used for antioxidant, hematological parameters, pro-inflammatory and inflammatory mediator, respectively. Histopathological observation was used to evaluate the protective effect of MM extract. RESULT & DISCUSSION: Current study confirmed the preventive effect of MM against adjuvant-induced paw edema, paw redness and arthritic progression. MM significantly (P < 0.001) modulated the oxidative stress parameters as well as hematological parameter induced by CFA. The result also altered the distorted level of proinflammatory mediators and inflammatory mediator, which further reinforce the implication of MM in CFA induced arthritis. Histological analyses of joints of rats showed a reduction in the synovial hyperplasia and mononuclear infiltration in the MM treated group which provides evidence for the antiarthritic effect of MM. CONCLUSION: From above parameters our study states that the MM is capable of restraining the alteration produced via adjuvant-induced arthritis in aminals. The repressing effect of MM could be attributed, at least in part, to antioxidant, hematological and anti-inflammatory effect. Figure Caption: Melastoma Malabathricum Linn Attenuates Complete Freund's Adjuvant-Induced Chronic Inflammation in Wistar rats by Inflammation Response.


Assuntos
Artrite/tratamento farmacológico , Inflamação/tratamento farmacológico , Melastomataceae , Fitoterapia , Extratos Vegetais/uso terapêutico , Animais , Antioxidantes/metabolismo , Artrite/sangue , Artrite/induzido quimicamente , Artrite/patologia , Cartilagem Articular/patologia , Avaliação Pré-Clínica de Medicamentos , Feminino , Adjuvante de Freund , Inflamação/sangue , Inflamação/induzido quimicamente , Masculino , Simulação de Acoplamento Molecular , Extratos Vegetais/química , Extratos Vegetais/toxicidade , Quercetina/análise , Distribuição Aleatória , Ratos Wistar
8.
Inflammopharmacology ; 24(5): 233-251, 2016 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-27628241

RESUMO

Melastoma malabathricum Linn (MM) has high valued for its commercial significance. Indian market (northeast) has great demand for the plants, which extended, its use as a traditional home remedy due to its anti-inflammatory effects. In this study, we scrutinize the therapeutic and protective effect of MM against diethylnitrosamine (DEN) and ferric nitrilotriacetate (Fe-NTA)-induced renal carcinogenesis, renal hyperproliferation, and oxidative stress in rats. Liquid chromatography mass spectroscopy (LC-MS) was used for identification of phytoconstituents. Administration of DEN confirmed the initiation the renal carcinogenesis via enhancing the expansion of tumor incidence. Intraperitoneally, administration of Fe-NTA boost the antioxidant enzymes (phase I), viz., superoxide dismutase (SOD), catalase (CAT), glutathione reductase (GR), glutathione peroxidase (GPx) and phase II, viz., quinone reductase (QR) and glutathione-S-transferase (GST). It also increased the content of renal lipid peroxidation (LPO), hydrogen peroxidase (H2O2) with decrease content in glutathione content (GSH). It also increased the renal biochemical and non-biochemical parameter. It also confirmed the augment the level of thymidine [3H] incorporation into renal DNA, ornithine decarboxylase (ODC) activity and increased the generation of proinflammatory (TNF-α, IL-6 and IL-ß) and inflammatory mediator (PGE2). We also analyzed the macroscopic and histologic of renal tissue. In addition, the effect of phytoconstituent of MM extract was evaluated in silico and free radical scavenging activity against the DPPH and ABTS free radicals. LC-MS confirmed the presence of quercetin >gallic acid in MM extract. Renal carcinogenesis rats treated with MM (100, 250, and 500 mg/kg) confirmed the significantly (P < 0.001) protective effect via reduction the antioxidant (phase I and phase II) enzymes, biochemical parameter and restore the proinflammatory and inflammatory mediator at dose dependent manner. MM altered the ODC and thymidine activity in renal DNA. The chemoprotective effect of MM was confirmed via decreased the renal tumor incidence, which was confirmed by the macroscopic and histopathological observation. Consequently, our result suggests that MM is a potent chemoprotective agent and suppresses DEN+ Fe-NTA-induced renal carcinogenesis, inflammatory reaction, and oxidative stress injury in Wister rats.


Assuntos
Biomarcadores Tumorais/metabolismo , Neoplasias Renais/tratamento farmacológico , Neoplasias Renais/metabolismo , Melastomataceae , Estresse Oxidativo/efeitos dos fármacos , Extratos Vegetais/uso terapêutico , Animais , Antineoplásicos Fitogênicos/isolamento & purificação , Antineoplásicos Fitogênicos/farmacologia , Antineoplásicos Fitogênicos/uso terapêutico , Biomarcadores Tumorais/antagonistas & inibidores , Compostos Férricos/toxicidade , Inflamação/tratamento farmacológico , Inflamação/metabolismo , Mediadores da Inflamação/antagonistas & inibidores , Mediadores da Inflamação/metabolismo , Neoplasias Renais/induzido quimicamente , Masculino , Ácido Nitrilotriacético/análogos & derivados , Ácido Nitrilotriacético/toxicidade , Estresse Oxidativo/fisiologia , Extratos Vegetais/isolamento & purificação , Extratos Vegetais/farmacologia , Distribuição Aleatória , Ratos , Ratos Wistar , Resultado do Tratamento , Carga Tumoral/efeitos dos fármacos , Carga Tumoral/fisiologia
9.
Inflammopharmacology ; 24(5): 277-286, 2016 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-27671329

RESUMO

This study was undertaken to investigate the effect of α-chymotrypsin on methyl nitrosourea (MNU) induced mammary gland carcinoma in albino wistar rats. Animals were randomized into four groups (six animals in each). Group I (sham control 0.9 % normal saline p.o.); Group II (toxic control, MNU 47 mg/kg, i.v.); Group III (α-chymotrypsin, 5 mg/kg, p.o.); Group IV (α-chymotrypsin, 10 mg/kg p.o.). Toxicity was induced by single i.v. injection of MNU followed by α-chymotrypsin supplementation therapy for 100 days. MNU treatment was evident with increased alveolar bud count, differentiation score, upregulated inflammatory enzymes markers (COX, LOX and NO) antioxidative stress markers (TBARs, SOD, catalase and GSH).MNU associated toxicity was also ascertained by PGP 9.5 and NF-κB expression in the mammary gland tissue followed by FAME analysis for fatty acid profiling. α-chymotrypsin afforded significant protection against the deleterious effects of MNU.


Assuntos
Quimotripsina/uso terapêutico , Ácidos Graxos não Esterificados/metabolismo , Neoplasias Mamárias Experimentais/tratamento farmacológico , Neoplasias Mamárias Experimentais/metabolismo , Metilnitrosoureia/toxicidade , Ubiquitina Tiolesterase/metabolismo , Animais , Bovinos , Feminino , Neoplasias Mamárias Experimentais/induzido quimicamente , Estresse Oxidativo/efeitos dos fármacos , Estresse Oxidativo/fisiologia , Ratos , Ratos Wistar
10.
BMC Complement Altern Med ; 16: 260, 2016 Jul 29.
Artigo em Inglês | MEDLINE | ID: mdl-27473871

RESUMO

BACKGROUND: The present study was in quested to study the effects of ß-sitosterol on methyl nitrosourea (MNU) induced mammary gland carcinoma in albino wistar rats. METHODS: Animals were randomized and divided into four groups of eight animals each. Group I (sham control 1 % CMC in normal saline p.o.); Group II (toxic control, MNU 47 mg/kg, i.v); Group III (MNU 47 mg/kg, i.v + ß-sitosterol, 10 mg/kg, p.o); Group IV (MNU 47 mg/kg, i.v + ß-sitosterol, 20 mg/kg, p.o). Toxicity was induced by single i.v. injection of MNU followed by ß-sitosterol supplementation therapy for 115 days at the dose mentioned above. RESULTS: Treatment with ß-sitosterol evidenced decrease in the alveolar bud and lobule score in the whole mount of the mammary gland. ß-sitosterol exhibited diminishing effect on oxidative stress through synchronizing lipid and enzymatic antioxidant defense. A significant decrease in the saturated and unsaturated fatty acid was evident with the MNU treatment and ß-sitosterol demonstrated a marked effect on it. Pgp 9.5 expression was dose dependently upregulated by ß-sitosterol treatment in comparison to MNU treatment. On the contrary, downregulated NF-kB expression was perceived, when ß-sitosterol was concomitantly administered with MNU. CONCLUSION: ß-sitosterol afforded significant protection against the deleterious effects of MNU.


Assuntos
Neoplasias Mamárias Experimentais/induzido quimicamente , Neoplasias Mamárias Experimentais/tratamento farmacológico , Metilnitrosoureia/efeitos adversos , Substâncias Protetoras/uso terapêutico , Animais , Feminino , Glândulas Mamárias Animais/efeitos dos fármacos , Glândulas Mamárias Animais/patologia , Substâncias Protetoras/química , Ratos , Ratos Wistar
11.
BMC Complement Altern Med ; 16: 99, 2016 Mar 10.
Artigo em Inglês | MEDLINE | ID: mdl-26965456

RESUMO

BACKGROUND: Methotrexate (MTX) is recognized as an anti-metabolite in cancer chemotherapy and is associated with various toxicities assigned to inflammation and oxidative stress. Rutin has been reported to have significant anti-inflammatory, antioxidant along with antiulcer properties. The present study was undertaken to corroborate the effect of rutin against MTX induced intestinal toxicity in experimental animals. METHOD: Six groups of rats (n = 6) were dosed with normal saline (3 ml/kg,i.p.); MTX (2.5 mg/kg,i.p.); rutin (50 and 100 mg/kg,i.p.); rutin + MTX (50 mg/kg + 2.5 mg/kg,i.p.); rutin + MTX (100 mg/kg + 2.5 mg/kg,i.p.) for seven consecutive days and sacrificed on eighth day. The intestinal contents were scrutinized physiologically (pH, total acidity, free acidity, CMDI), biochemically (TBARS, protein carbonyl, SOD, catalase and GSH) and for immunoregulatory cytokines (IL-2, IL-4 and IL-10). RESULTS AND DISCUSSION: The administration of rutin demonstrated significant protection against intestinal lesions damaged by MTX. The treatment with rutin elicited noticeable inhibition of free acidity (26.20%), total acidity (22.05%) and CMDI (1.16%) in the experimental animals similar to control. In MTX treated toxic group, the levels of oxidative markers and immunoregulatory cytokines significantly increased in comparison to control, which was subsequently restored after rutin treatment. Rutin also demonstrated 75.63, 81.00 and 80.43% inhibition of cyclooxygenase-1 and 2, and 15-lipoxygenase respectively. CONCLUSION: The positive modulation of MTX toxicity could be attributed to the free radical scavenging and anti-inflammatory (dual inhibition of arachidonic acid pathways) potential of rutin.


Assuntos
Anti-Inflamatórios/uso terapêutico , Antioxidantes/uso terapêutico , Intestinos/efeitos dos fármacos , Metotrexato/efeitos adversos , Fitoterapia , Extratos Vegetais/uso terapêutico , Rutina/uso terapêutico , Ácidos/metabolismo , Animais , Anti-Inflamatórios/farmacologia , Antimetabólitos Antineoplásicos/efeitos adversos , Antioxidantes/farmacologia , Araquidonato 15-Lipoxigenase/metabolismo , Citocinas/metabolismo , Inflamação/prevenção & controle , Enteropatias/metabolismo , Enteropatias/prevenção & controle , Intestinos/patologia , Estresse Oxidativo/efeitos dos fármacos , Extratos Vegetais/farmacologia , Prostaglandina-Endoperóxido Sintases/metabolismo , Ratos Wistar , Rutina/farmacologia
12.
BMC Complement Altern Med ; 15: 110, 2015 Apr 09.
Artigo em Inglês | MEDLINE | ID: mdl-25888837

RESUMO

BACKGROUND: Lycopene is a robust antioxidant with significant antiulcer activity. Henceforth, the present study was ventured to elucidate the effect of lycopene on experimental esophagitis. METHODS: Groups of rats were subjected to forestomach and pylorus ligation with subsequent treatment with lycopene (50 and 100 mg/kg, po) and pantoprazole (30 mg/kg, po). RESULTS: Treatment with lycopene evidenced sententious physiological protection when scrutinized for pH, acidity (total and free), volume of gastric juices and esophagitis index. Lycopene further embarked diminishing effect on oxidative stress through synchronising lipid and protein peroxidation along with regulating the enzymatic activity of SOD and catalase. Lycopene also modified the levels of immunoregulatory cytokines (IL- 1ß and IL-6) favourably. The dose dependent efficacy of lycopene in the current experimental condition was also attested when exemplified morphologically through scanning electron microscopy. CONCLUSION: From the current line of evidences, it was concluded that lycopene can impart momentous protection against experimental esophagitis by wrapping up the reactive oxygen species and through dual inhibition of the arachidonic acid pathway.


Assuntos
Antioxidantes/uso terapêutico , Carotenoides/uso terapêutico , Esofagite/prevenção & controle , Refluxo Gastroesofágico/tratamento farmacológico , Estresse Oxidativo/efeitos dos fármacos , Fitoterapia , Extratos Vegetais/uso terapêutico , 2-Piridinilmetilsulfinilbenzimidazóis/uso terapêutico , Animais , Antioxidantes/metabolismo , Antioxidantes/farmacologia , Carotenoides/farmacologia , Catalase/metabolismo , Esofagite/metabolismo , Suco Gástrico/metabolismo , Refluxo Gastroesofágico/metabolismo , Interleucina-1beta/metabolismo , Interleucina-6/metabolismo , Licopeno , Masculino , Pantoprazol , Extratos Vegetais/farmacologia , Inibidores da Bomba de Prótons/uso terapêutico , Ratos Wistar
13.
Inflammopharmacology ; 23(1): 65-70, 2015 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-25490949

RESUMO

The present work investigates the anti-inflammatory, analgesic and antipyretic activity of methanolic extract of mulberry leaves of variety S-1, S-13 and S-146. The S-146 extract was further evaluated for its efficacy against adjuvant arthritis in albino rats followed by inhibitory potential for COX 1, COX 2 and 5 LOX. The HPLC analysis enumerated the presence of morin, reversterol, scopoletin and 7-hydroxy coumarin as the major constituents. The anti-inflammatory, antipyretic and analgesic activity observed in the present experiment could be accredited to the dual inhibition in the AA pathway. The inhibition of COX and LOX enzymes could be imparted to the presence of resveraterol, morin, scopoletin and 7-hydroxy coumarin.


Assuntos
Ácido Araquidônico/antagonistas & inibidores , Morus , Extratos Vegetais/farmacologia , Folhas de Planta , Transdução de Sinais/efeitos dos fármacos , Animais , Ácido Araquidônico/metabolismo , Feminino , Masculino , Camundongos , Extratos Vegetais/isolamento & purificação , Ratos , Ratos Wistar , Transdução de Sinais/fisiologia
14.
Indian J Pharmacol ; 47(6): 644-8, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26729957

RESUMO

OBJECTIVE: The ability of Luffa cylindrica Roem fruit extract (LCE) to modulate biochemical parameters was investigated by in vitro studies for its role in hydrogen peroxide induced cataract on isolated goat lenses which were incubated for 72 h at 37°C. MATERIALS AND METHODS: Test groups contained 5, 10, 15, 20, 25, and 30 µg/ml of LCE along with 1 ml of H2O2 (0.5 mM) as cataract inducer. Lenses were examined for morphological variation and transparency periodically during the incubation. Biochemical parameters such as superoxide dismutase (SOD), reduced glutathione (GSH), total protein content (TPC), and malondialdehyde (MDA) were estimated. RESULTS: SOD, GSH, and TPC levels were found to increase proportionally with the concentration of LCE. However, MDA levels were found to be inversely proportional to the concentration of LCE. Opacity was graded as per "lens opacities classification system III." Morphological examination suggested that LCE (25 µg/ml) maintained a vision for 44 h. No lens in LCE dose groups developed dense nuclear opacity after 24 h as opposed to 80% in negative control. CONCLUSION: The results suggest that LCE can delay the onset and/or prevent the progression of cataract which can be attributed to the presence of adequate phenolics, flavonoids, and Vitamin A and its high nutritional value. This preliminary study can be further synergized by testing LCE against other in vivo and in vitro models of cataract.


Assuntos
Antioxidantes/farmacologia , Catarata/prevenção & controle , Frutas/química , Cristalino/efeitos dos fármacos , Luffa/química , Estresse Oxidativo/efeitos dos fármacos , Extratos Vegetais/farmacologia , Animais , Antioxidantes/química , Catarata/induzido quimicamente , Catarata/metabolismo , Catarata/patologia , Proteínas do Olho/metabolismo , Flavonoides/análise , Flavonoides/farmacologia , Glutationa/metabolismo , Cabras , Peróxido de Hidrogênio/antagonistas & inibidores , Peróxido de Hidrogênio/toxicidade , Cristalino/metabolismo , Cristalino/patologia , Peroxidação de Lipídeos/efeitos dos fármacos , Malondialdeído/metabolismo , Oxidantes/antagonistas & inibidores , Oxidantes/toxicidade , Oxirredução , Fenóis/análise , Fenóis/farmacologia , Extratos Vegetais/química , Superóxido Dismutase/metabolismo , Técnicas de Cultura de Tecidos
15.
Inflammation ; 37(4): 1297-306, 2014 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-24639012

RESUMO

The present work investigates the anti-inflammatory activity of alpha-linolenic acid (ALA) and linoleic acid (LA) using computational and experimental analysis. The binding affinity of ALA and LA was appraised for cyclooxygenase 1 (COX-1), cyclooxygenase 2 (COX-2), and 5-lipoxygenase (5-LOX) using AutoDock 4.2 and AutoDock Vina 1.1.2. Anti-inflammatory activity of ALA (2 and 4 ml/kg, i.p.) (55.65 % v/v) and LA (2 and 4 ml/kg, i.p.) (55 % v/v) was further assayed using the rat paw edema test against a variety of phlogistic agents including carrageenan, arachidonic acid, prostaglandin, and leukotriene, respectively. ALA (2 and 4 ml/kg, i.p.) and LA (2 and 4 ml/kg, i.p.) were further tested for their efficacy against complete Freund's adjuvant (CFA)-induced (0.05 ml) arthritis in albino rats. Following CFA-induced arthritis, ALA and LA were tested for their inhibitory proficiency against COX-1, COX-2, and 5-LOX in vitro. The present study commends that the anti-inflammatory potential of ALA could be attributed to COX inhibition, in particular, COX-2.


Assuntos
Anti-Inflamatórios/química , Araquidonato 5-Lipoxigenase/metabolismo , Ciclo-Oxigenase 1/metabolismo , Ciclo-Oxigenase 2/metabolismo , Inibidores de Ciclo-Oxigenase/química , Ácido alfa-Linolênico/química , Sequência de Aminoácidos , Animais , Ácido Araquidônico/química , Artrite/fisiopatologia , Carragenina/química , Edema , Leucotrienos/química , Inibidores de Lipoxigenase/química , Simulação de Acoplamento Molecular , Dados de Sequência Molecular , Prostaglandinas/química , Conformação Proteica , Ratos , Ratos Wistar
16.
Biomed Res Int ; 2013: 981372, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24027769

RESUMO

The present study was undertaken to elucidate the effect of Perilla frutescens fixed oil on experimental esophagitis in albino rats. A group of rats (n = 6), treated with control vehicle (0.9% NaCl in double distilled water, 3 mL/kg, i.p.) and Perilla frutescens fixed oil (100%) (1, 2, and 3 mL/kg, i.p.), or pantoprazole (30 mg/kg, i.p.), were subjected to pylorus and forestomach ligation. Animals were sacrificed after 6 h and evaluated for the gastric pH, volume of gastric juices, total acidity, esophagitis index and free acidity. Esophageal tissues were further subjected to estimations of TBARS, GSH, catalase, and SOD. Treatment with fixed oil significantly inhibited the gastric secretion, total acidity, and esophagitis index. The oil also helped to restore the altered levels of oxidative stress parameters to normal. The present study also makes evident the in vitro antihistaminic and anticholinergic activity of alpha linolenic acid (ALA) (18 : 3, n - 3) on isolated rat ileum preparation. The lipoxygenase inhibitory, histamine antagonistic, antisecretory (anticholinergic), and antioxidant activity of the oil was attributed for its efficacy in reflux esophagitis.


Assuntos
Esofagite/tratamento farmacológico , Estresse Oxidativo/efeitos dos fármacos , Perilla frutescens/química , Óleos de Plantas/administração & dosagem , 2-Piridinilmetilsulfinilbenzimidazóis/administração & dosagem , Animais , Catalase/metabolismo , Esofagite/patologia , Masculino , Pantoprazol , Óleos de Plantas/química , Ratos , Ratos Wistar , Superóxido Dismutase/metabolismo , Substâncias Reativas com Ácido Tiobarbitúrico/metabolismo , Ácido alfa-Linolênico/administração & dosagem
17.
Asian Pac J Trop Biomed ; 2(3): 185-8, 2012 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-23569895

RESUMO

OBJECTIVE: To evaluate the antiarthritic activity of Ajuga bracteosa using albino rats. METHODS: The antiarthritic activity of 70% ethanolic extract of Ajuga bracteosa (EEAB) was evaluated against turpentine oil- and formaldehyde- induced acute non immunological and complete freund's adjuvant (CFA)-induced chronic immunological arthritis in albino rats. RESULTS: EEAB showed a significant (P<0.05) and dose dependent inhibitory effect against acute and chronic models of arthritis. EEAB exhibited better antiarthritic activity than the standard aspirin. CONCLUSIONS: EEAB exhibits a significant and promising antiarthritic activity against acute and chronic arthritis and supports the traditional use of Ajuga bracteosa for rheumatism and other inflammatory diseases.


Assuntos
Ajuga/química , Anti-Inflamatórios/farmacologia , Artrite/tratamento farmacológico , Extratos Vegetais/farmacologia , Animais , Anti-Inflamatórios/química , Anti-Inflamatórios/uso terapêutico , Artrite/diagnóstico por imagem , Artrite/patologia , Artrografia , Doença Crônica , Modelos Animais de Doenças , Edema/tratamento farmacológico , Edema/patologia , Articulações/efeitos dos fármacos , Articulações/patologia , Extratos Vegetais/química , Extratos Vegetais/uso terapêutico , Ratos , Ratos Wistar
18.
Indian J Exp Biol ; 49(4): 260-8, 2011 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-21614889

RESUMO

Administration of a single dose of doxorubicin (DOX) (7.5 mg/kg, i.v.) produces cardiotoxicity, manifested biochemically by significant decrease in blood glutathione (GSH) and tissue GSH along with elevated levels of serum lactate dehydrogenase (LDH) and serum creatine phosphokinase (CPK). In addition, cardiotoxicity was further confirmed by significant increase in lipid peroxides expressed as malondialdehyde (MDA, secondary indicator of lipid peroxidation), tissue catalase and tissue superoxide dismutase (SOD). Administration ofA. vera gel (100 and 200 mg/kg) orally for 10 days produced a significant protection against cardiotoxicity induced by DOX evidenced by significant reductions in serum LDH, serum CPK, cardiac lipid peroxides, tissue catalase and tissue SOD along with increased levels of blood and tissue GSH. The results revealed that A. vera gel produced a dose dependent protection against DOX induced cardiotoxiaty.


Assuntos
Aloe , Cardiotônicos/administração & dosagem , Doxorrubicina/antagonistas & inibidores , Coração/efeitos dos fármacos , Administração Oral , Animais , Cálcio/metabolismo , Doxorrubicina/toxicidade , Feminino , Géis , Masculino , Miocárdio/metabolismo , Miocárdio/patologia , Estresse Oxidativo/efeitos dos fármacos , Fitoterapia , Extratos Vegetais/administração & dosagem , Plantas Medicinais , Ratos
19.
Inflammopharmacology ; 19(1): 45-52, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-20602175

RESUMO

PURPOSE: In vitro antimicrobial activity and in vivo therapeutic efficacy of L. usitatissimum (linseed/flaxseed) fixed oil in bovine mastitis were investigated. METHOD: In vitro antimicrobial activity of L. usitatissimum fixed oil was evaluated against a number of microorganisms by disc diffusion method and MIC determination. The in vivo efficacy of the oil was evaluated in nine mastitis-affected cows divided into three groups (three in each group), following once-a-day intramammary infusion of oil, cefoperazone or an oil-cefoperazone combination for 7 days and by monitoring the California mastitis test score, somatic cell count and microbial count in milk samples. RESULTS: The in vitro antimicrobial activity of the oil against Staphylococcus aureus, Streptococcus agalactiae and Escherichia coli was comparable to that of cefoperazone while the antimicrobial activity against Enterococcus faecalis, Micrococcus luteus and Candida albicans, was greater than that of cefoperazone. In the in vivo study, the oil exhibited significant reduction in the California mastitis test score and somatic cell count in milk samples from infected udders following 7 days of intramammary administration suggesting its anti-inflammatory effect. The microbial count in milk samples was also reduced significantly following oil treatment. The effects were comparable to the treatment by cefoperazone (Mastiwock) alone or in combination with the oil. Apparently, the anti-inflammatory and antimicrobial properties of the oil contribute to its therapeutic efficacy in mastitis; the oil could be used as an alternative treatment for bovine mastitis CONCLUSION: The results suggest possible therapeutic potential of L. usitatissimum fixed oil in bovine mastitis.


Assuntos
Anti-Infecciosos/farmacologia , Linho/química , Óleo de Semente do Linho/farmacologia , Mastite Bovina/tratamento farmacológico , Animais , Anti-Infecciosos/química , Anti-Infecciosos/isolamento & purificação , Anti-Inflamatórios/química , Anti-Inflamatórios/isolamento & purificação , Anti-Inflamatórios/farmacologia , Bactérias/efeitos dos fármacos , Candida albicans/efeitos dos fármacos , Bovinos , Cefoperazona/farmacologia , Escherichia coli/efeitos dos fármacos , Feminino , Óleo de Semente do Linho/química , Óleo de Semente do Linho/isolamento & purificação , Mastite Bovina/microbiologia , Testes de Sensibilidade Microbiana , Leite/efeitos dos fármacos , Leite/microbiologia , Staphylococcus aureus/efeitos dos fármacos , Streptococcus agalactiae/efeitos dos fármacos
20.
Indian J Exp Biol ; 49(12): 932-8, 2011 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-22403867

RESUMO

The fixed oil of L. usitatissimum (flaxseed/linseed) inhibited PGE2-, leukotriene-, histamine- and bradykinin-induced inflammation. The oil also inhibited arachidonic acid-induced inflammation, suggesting its capacity to inhibit both cyclooxygenase and lipoxygenase pathways of arachidonate metabolism. In tail immersion model, the oil raised the pain threshold to a lesser extent than morphine but showed excellent peripherally acting, analgesic activity comparable to aspirin, against acetic acid-induced writhing in mouse. In typhoid paratyphoid A/B vaccine-induced pyrexia, the oil showed antipyretic activity comparable to aspirin. The oil contains 57.38% alpha-linolenic acid. Dual inhibition of arachidonic acid metabolism, antihistaminic and antibradykinin activities of the oil could account for the biological activity and the active principle could be alpha-linolenic acid an omega-3 (18:3, n-3) fatty acid.


Assuntos
Analgésicos não Narcóticos/farmacologia , Anti-Inflamatórios/farmacologia , Antipiréticos/farmacologia , Linho/química , Óleo de Semente do Linho/farmacologia , Analgésicos não Narcóticos/isolamento & purificação , Analgésicos não Narcóticos/uso terapêutico , Analgésicos não Narcóticos/toxicidade , Animais , Anti-Inflamatórios/isolamento & purificação , Anti-Inflamatórios/uso terapêutico , Anti-Inflamatórios/toxicidade , Antipiréticos/isolamento & purificação , Antipiréticos/uso terapêutico , Antipiréticos/toxicidade , Modelos Animais de Doenças , Edema/tratamento farmacológico , Febre/tratamento farmacológico , Óleo de Semente do Linho/isolamento & purificação , Óleo de Semente do Linho/uso terapêutico , Óleo de Semente do Linho/toxicidade , Camundongos , Dor/tratamento farmacológico , Ratos , Ratos Wistar , Sementes/química , Testes de Toxicidade Aguda , Testes de Toxicidade Subaguda
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA